Molecular mechanisms of HLA association with autoimmune diseases

Tissue Antigens

Volumn 73, Issue 1, 2009, Pages 1-8

  Caillat Zucman, S ^a,b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Ankylosing spondilitis; Celiac disease; Genetic predisposition; Human leukocyte antigen association; Narcolepsy; Peptide binding; Type 1 diabetes

Indexed keywords

HLA ANTIGEN; HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; CELIAC DISEASE; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALLELES; ANIMALS; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; NARCOLEPSY; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING;

EID: 58149133611     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01167.x     Document Type: Review

References (57)

1. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004 : 64 : 631 49.
2. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997 : 40 : 1823 8.
3. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990 : 63 : 1099 112.
4. Marcilla M, Lopez de Castro JA. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 2008 : 71 : 495 506.
5. Matsuki K, Grumet FC, Lin X et al. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 1992 : 339 : 1052.
6. Peyron C, Faraco J, Rogers W et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000 : 6 : 991 7.
7. Siebold C, Hansen BE, Wyer JR et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 2004 : 101 : 1999 2004.
8. Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics 2008 : 60 : 275 86.
9. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008 : 9 : 516 26.
10. de Vries RR, Huizinga TW, Toes RE. HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA. Hum Immunol 2006 : 67 : 454 9.
11. Jones EY, Fugger L, Strominger JL, Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006 : 6 : 271 82.
12. Maki M, Mustalahti K, Kokkonen J et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003 : 348 : 2517 24.
13. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002 : 2 : 647 55.
14. Greco L, Romino R, Coto I et al. The first large population based twin study of coeliac disease. Gut 2002 : 50 : 624 8.
15. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993 : 178 : 187 96.
16. Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerance in celiac sprue. Science 2002 : 297 : 2275 9.
17. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008 : 205 : 143 54.
18. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997 : 3 : 797 801.
19. Molberg O, Mcadam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998 : 4 : 713 7.
20. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996 : 8 : 177 82.
21. van de Wal Y, Kooy YM, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 1996 : 44 : 246 53.
22. Kwok WW, Domeier ML, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 1996 : 156 : 2171 7.
23. Godkin A, Friede T, Davenport M et al. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol 1997 : 9 : 905 11.
24. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005 : 129 : 1294 301.
25. Vader LW, de Ru A, van der Wal Y et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002 : 195 : 643 9.
26. Tollefsen S, Arentz-Hansen H, Fleckenstein B et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006 : 116 : 2226 36.
27. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001 : 2 : 501 7.
28. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 2004 : 101 : 4175 9.
29. Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease-associated HLA-DQ2 molecule. J Biol Chem 2005 : 280 : 21791 6.
30. Arentz-Hansen H, McAdam SN, Molberg O et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002 : 123 : 803 9.
31. Henderson KN, Tye-Din JA, Reid HH et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 2007 : 27 : 23 34.
32. Atkinson MA, Kaufman DL, Campbell L et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992 : 339 : 458 9.
33. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 2002 : 109 : 895 903.
34. Alleva DG, Crowe PD, Jin L et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001 : 107 : 173 80.
35. Wong FS, Karttunen J, Dumont C et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999 : 5 : 1026 31.
36. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004 : 114 : 589 97.
37. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996 : 59 : 1134 48.
38. Sheehy MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989 : 83 : 830 5.
39. Thomson G, Valdes AM, Noble JA et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007 : 70 : 110 27.
40. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008 : 57 : 1084 92.
41. Undlien DE, Thorsby E. HLA associations in type 1 diabetes: merging genetics and immunology. Trends Immunol 2001 : 22 : 467 9.
42. Harfouch-Hammoud E, Timsit J, Boitard C, Bach JF, Caillat-Zucman S. Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of dq. J Autoimmun 1996 : 9 : 411 4.
43. Caillat-Zucman S, Garchon HJ, Timsit J et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992 : 90 : 2242 50.
44. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987 : 329 : 599 604.
45. Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A 1988 : 85 : 6012 6.
46. Fremont DH, Monnaie D, Nelson CA, Hendrickson WA, Unanue ER. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 1998 : 8 : 305 17.
47. Scott CA, Peterson PA, Teyton L, Wilson IA. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 1998 : 8 : 319 29.
48. Corper AL, Stratmann T, Apostolopoulos V et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000 : 288 : 505 11.
49. Svejgaard A, Ryder LP. HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet 1981 : 45 : 293 8.
50. Kent SC, Chen Y, Bregoli L et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005 : 435 : 224 8.
51. Mannering SI, Harrison LC, Williamson NA et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005 : 202 : 1191 7.
52. Martinuzzi E, Novelli G, Scotto M et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 2008 : 57 : 1312 20.
53. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med 1995 : 1 : 576 82.
54. Nejentsev S, Howson JM, Walker NM et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007 : 450 : 887 92.
55. Nakanishi K, Inoko H. Combination of HLA-A24, -DQA1*03, and -DR9 contributes to acute-onset and early complete beta-cell destruction in type 1 diabetes: longitudinal study of residual beta-cell function. Diabetes 2006 : 55 : 1862 8.
56. Pugliese A, Gianani R, Moromisato R et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 1995 : 44 : 608 13.
57. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001 : 2 : 91 9.